Walrus Lifesciences Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
as on 21-06-2024
- Paid Up Capital ₹ 1.20 M
as on 21-06-2024
- Company Age 16 years 7 months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.10 M
as on 21-06-2024
- Revenue -0.32%
FY 2019
- Profit 35.71%
FY 2019
- Ebitda 559.69%
FY 2019
- Net Worth 8.06%
FY 2019
- Total Assets -10.75%
FY 2019
About Walrus Lifesciences
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.20 M.
The Corporate currently has active open charges totaling ₹5.10 M.
Rakesh Arun and Sweta Verma serve as directors at the Company.
- CIN/LLPIN
U24239BR2008PTC013428
- Company No.
013428
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Walrus Lifesciences?
Board Members(2)
Financial Performance and Corporate Structure Insights of Walrus Lifesciences.
Walrus Lifesciences Private Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 0.32% decrease. The company also saw a substantial improvement in profitability, with a 35.71% increase in profit. The company's net worth moved up by a moderate rise of 8.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| FY 2022 | FY 2021 | FY 2020 | FY 2019 | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Walrus Lifesciences?
In 2018, Walrus Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
25 years 1 day Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Jul 2022 | ₹0.15 M | Open |
Others Creation Date: 29 Apr 2020 | ₹0.45 M | Open |
Others Creation Date: 17 Feb 2011 | ₹4.50 M | Open |
How Many Employees Work at Walrus Lifesciences?
Unlock and access historical data on people associated with Walrus Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Feb 04, 2009, Walrus Lifesciences has raised a total of ₹ 0.7 M, with the most recent deal valued at ₹ 0.7 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
